PharmaLundensis
0,05 SEK
-1,88 %
PHAL
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.
Læs mereOmsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
Delårsrapport Q1'26
Generalforsamling '26
Delårsrapport Q2'26